Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Net Cash Flow came in at -$4.0 million in Q1 2026, down 107.45% year-on-year from $53.3 million in Q1 2025, and up 96.69% quarter-over-quarter from -$119.9 million in Q4 2025.
Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Net Cash Flow across 8 years of filings, most recently posting -$4.0 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$4.0 million, down 107.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$52.6 million (down 131.13% YoY), and the FY2025 annual result was $4.7 million, down 96.24% from the prior year.
- Net Cash Flow came in at -$4.0 million for Q1 2026 at Hims & Hers Health, up from -$119.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $849.0 million in Q2 2025 to a low of -$777.7 million in Q3 2025.
- The 5-year median for Net Cash Flow is $6.8 million (2022), against an average of $8.8 million.
- Peak annual rise in Net Cash Flow reached 3428.68% in 2025, while the deepest fall reached 2258.26% in 2025.
- Hims & Hers Health's Net Cash Flow stood at -$11.2 million in 2022, then soared by 446.44% to $38.7 million in 2023, then surged by 43.43% to $55.5 million in 2024, then tumbled by 315.91% to -$119.9 million in 2025, then soared by 96.69% to -$4.0 million in 2026.
- The last three Net Cash Flow figures came in at -$4.0 million (Q1 2026), -$119.9 million (Q4 2025), and -$777.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 32.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.97 Mn |
| Mar 31, 2026 | -3.97 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Dec 31, 2025 | -119.89 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Sep 30, 2025 | -777.69 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Jun 30, 2025 | 848.96 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Mar 31, 2025 | 53.28 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Dec 31, 2024 | 55.53 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Sep 30, 2024 | 36.03 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 38.72 Mn |
| Dec 31, 2023 | 38.72 Mn |